Pro Medicus Limited (OTCMKTS:PMCUF – Get Free Report)’s share price gapped down prior to trading on Thursday . The stock had previously closed at $144.00, but opened at $129.41. Pro Medicus shares last traded at $129.41, with a volume of 1,000 shares trading hands.
Analysts Set New Price Targets
Separately, Jefferies Financial Group lowered shares of Pro Medicus from a “buy” rating to a “hold” rating in a report on Wednesday, July 8th. One investment analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, Pro Medicus presently has a consensus rating of “Hold” and a consensus price target of $155.00.
Check Out Our Latest Stock Analysis on PMCUF
Pro Medicus Trading Down 2.0%
Pro Medicus Company Profile
Pro Medicus Limited is an Australia‐based healthcare technology company specializing in advanced medical imaging IT solutions. Its core offerings include radiology information systems (RIS), picture archiving and communication systems (PACS), and enterprise imaging platforms designed to streamline diagnostic workflows and enhance image management for healthcare providers.
The company’s flagship product suite, Visage 7, delivers high-performance visualization and reporting capabilities, enabling radiologists to access and manipulate large datasets with minimal latency.
Recommended Stories
- Five stocks we like better than Pro Medicus
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Receive News & Ratings for Pro Medicus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro Medicus and related companies with MarketBeat.com's FREE daily email newsletter.
